Emergent BioSolutions (EBS) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.32 -0.83%
Revenue Growth %: +32.0%
Financial Fact:
Interest income: 358K
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +32.0%
Financial Fact:
Interest income: 358K
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $307.5 million versus the consensus estimate of $283.57 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- BIG3 Basketball to go public via Graf Global merger at $290 million
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
